The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.
Kotb, M. (2012). The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.. EKB Journal Management System, 6(6), 40-54. doi: 10.21608/egyjnm.2012.5475
Magdy Kotb. "The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.". EKB Journal Management System, 6, 6, 2012, 40-54. doi: 10.21608/egyjnm.2012.5475
Kotb, M. (2012). 'The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.', EKB Journal Management System, 6(6), pp. 40-54. doi: 10.21608/egyjnm.2012.5475
Kotb, M. The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.. EKB Journal Management System, 2012; 6(6): 40-54. doi: 10.21608/egyjnm.2012.5475

The Effects of TSH level on the Results of F-18 FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma Patients with Elevated Serum Thyroglobulin Level and Negative I-131 WBS.

Egyptian Journal Nuclear Medicine
Article 5, Volume 6, Issue 6, December 2012, Page 40-54  XML PDF (243.43 K)
Document Type: Original Paper, Oncology
DOI: 10.21608/egyjnm.2012.5475
View on SCiNiTO View on SCiNiTO
Author
Magdy Kotb email
National Cancer Institute , Cairo University
Abstract
Purpose : To assess the effects of TSH level on F-18 FDG PET-CT results & its impact on serum thyroglobulin (TG) cut off point and management in recurrent DTC patients with elevated TG level & negative I-131 WBS. Material
and Methods: This prospective work involved 38 histopathologically proved DTC patients underwent total thyroid ablation with elevated serum TG and negative I-131 WBS during follow up. F-18 FDG was done in all patients using standard technique. Results: Patients divided into two groups: (I) Stimulated TSH group (i.e. TSH level > 30 IU/L, 60 ± 20 IU/L): 20 patients. (II) Suppressed TSH group (i.e. TSH level <0.1 IU/L, 0.007 ± 0.003IU/L): 18 patients. Significantly higher overall accuracy, sensitivity & NPV were found in stimulated group (98.5%, 88.6%, 62% respectively) compared to the suppressed group (66%, 62% & 31.5% respectively) that was more obvious in nodal rather than pulmonary deposits (P<0.05). However no significant difference was demonstrated in specificity & PPV between both groups. Significantly lower TG cut off point was demonstrated in stimulated group (15 ng/ml) compared to suppressed group (21 ng/ml) (P<0.05). Moreover significantly higher impact of F-18 FDG PET-CT in TSH stimulated (40%) was demonstrated compared to TSH suppressed (11.2%) group on patient management.
Conclusion: High TSH seems to enhance F-18 FDG PET/CT efficiency on nodal rather than pulmonary metastases in recurrent DTC patients with elevated serum TG level and negative I-131 WBS. Moreover it reduces TG cut off point for F-18 FDG PET-CT & escalates its impact on patient management.

Keywords
FDG PET/CT; TSH; De-DTC
Statistics
Article View: 138
PDF Download: 196